NCT03524456

Brief Summary

Hypertension is a public health problem worldwide, being responsible for 9.4 million deaths worldwide each year, as well as contributing to the burden of coronary, cerebrovascular, renal diseases, among others. The monitoring of blood pressure at home has gained importance in recent years, being related to adherence to treatment, as well as in the prevention of complications and optimization of pressure levels; In the same way, the use of information and communication technologies (ICT) in health has contributed to the improvement of communication systems by providing alternative tele-monitoring in this type of diseases. Objective: To evaluate the impact of tele-monitoring at home through tensiometers with integrated SMS system (text message), for the sending and recording of blood pressure and heart rate data in the primary care setting. Methods: A randomized controlled trial will be conducted, evaluating the intervention with the integrated blood pressure device with SMS capability, comparing it with the standard care. After a follow-up of 1 month, the effect on the values of systolic and diastolic blood pressure will be evaluated, as well as the adherence to treatment and complications related to arterial hypertension. A sample number of 20 participants per group was calculated, with a significance of 95% and a power of 80%, to detect a minimum significant difference of 10 mmHg.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at below P25 for not_applicable hypertension

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 9, 2018

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

May 2, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 14, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 29, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 29, 2018

Completed
Last Updated

May 7, 2019

Status Verified

May 1, 2019

Enrollment Period

5 months

First QC Date

May 2, 2018

Last Update Submit

May 3, 2019

Conditions

Keywords

home blood pressure monitoringsmsprimary care

Outcome Measures

Primary Outcomes (1)

  • Comparison of blood pressure diference before and after the intervention period between the control and intervention arm

    Changes in the blood pressure levels would be compare in both study groups

    1 month

Study Arms (2)

Home blood pressure monitoring

EXPERIMENTAL
Other: Home blood pressure monitoring

Usual monitoring

NO INTERVENTION

Interventions

Participants would use a blood pressure device at home, that sends the readings automatically to the health center via SMS. The physicians would use this tool for medication management or rescheduling visits.

Home blood pressure monitoring

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Older than 18 years-old.
  • Diagnosis of hypertension more than 3 months ago.
  • Not Controlled hypertension
  • In antihypertensive medication

You may not qualify if:

  • Patient with chronic kidney disease on hemodialysis or peritoneal dialysis.
  • Pregnant women.
  • Travel or change of address in the next 4 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro de Salud Condevilla

Lima, Peru

Location

MeSH Terms

Conditions

HypertensionSmith-Magenis Syndrome

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesChronobiology DisordersNervous System DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesChromosome DisordersGenetic Diseases, Inborn

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

May 2, 2018

First Posted

May 14, 2018

Study Start

April 9, 2018

Primary Completion

August 29, 2018

Study Completion

September 29, 2018

Last Updated

May 7, 2019

Record last verified: 2019-05

Locations